Overview

Long-term Administration Study of SND 919 Tablets in Parkinson's Disease

Status:
Completed
Trial end date:
2004-02-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of long-term treatment with pramipexole tablets (BI Sifrol®) in Parkinson's disease (phase III study).
Phase:
Phase 3
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Pramipexole